Joshua Levin, PhD, is a Senior Group Leader and Research Scientist in the Broad Institute of MIT and Harvard’s Stanley Center for Psychiatric Research, as well as in the Klarman Cell Observatory. In his research, he uses transcriptomic approaches to improve our understanding of brain function as it relates to disorders such as autism, schizophrenia and Parkinson’s disease.

During his time at the Broad Institute, Dr. Levin has developed and comprehensively evaluated an extensive portfolio of RNA sequencing (RNA-Seq) methods such as targeted, strand-specific, total, low-input, 5’ end and single cell RNA-Seq protocols. His group performed single cell RNA-Seq in a seminal study on single-cell level heterogeneity in immune cells.